Anti-Kickback Statute

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT

Retrieved on: 
Saturday, October 22, 2022
Pomerantz, Genetics, Physician, Remuneration, News, U.S. Securities and Exchange Commission, Office of Inspector General, U.S. Department of Health and Human Services, Anti-Kickback Statute, SEC, Reward, Person, NASDAQ, Complaint, Patient, Federal, Court, Company, Justice, U.S. Department of Justice Office of Legislative Affairs, Battle of Saint-Fulgent, Medicare, District court, Securities Exchange Act of 1934, Lists of schools in England, Genetic testing, SEC Rule 10b-5, GLOBE, Central District, Ext, Disclosure, LLP, COVID-19, Stark Law, Health, Lists of action films, Online gambling, Pharmaceutical industry

NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.

Key Points: 
  • NEW YORK, Oct. 22, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.
  • If you are a shareholder who purchased Fulgent securities during the Class Period, you have until November 21, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

ROSEN, A TOP RANKED FIRM, Encourages Fulgent Genetics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

Retrieved on: 
Saturday, October 22, 2022
Titan, LinkedIn, Genetics, Remuneration, Advertising, Class, Reward, THE, NASDAQ, Federal, Twitter, Court, Facebook, Anti-Kickback Statute, Battle of Saint-Fulgent, Medicare, WHY, TO, Lists of schools in England, GLOBE, Stark Law, Health, I-Space (Chinese company), Online gambling, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT)

Retrieved on: 
Friday, October 21, 2022
Remuneration, Genetics, News, Time, Privacy Office of the U.S. Department of Homeland Security, Anti-Kickback Statute, SEC, NASDAQ, Court, Investment, Securities Exchange Act of 1934, Justice, U.S. Department of Justice Office of Legislative Affairs, Company, Defendant, Stark, Lists of schools in England, Exchange, GLOBE, GPM, Suite, Stark Law, Pharmaceutical industry, Battle of Saint-Fulgent

You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.

Key Points: 
  • You can also contact Charles H. Linehan, of GPM at 310-201-9150, Toll-Free at 888-773-9224, or via email at [email protected] to learn more about your rights.
  • If you purchased or otherwise acquired Fulgent securities during the Class Period, you may move the Court no later than November 21, 2022 to request appointment as lead plaintiff in this putative class action lawsuit.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
  • Glancy Prongay & Murray LLP, Los Angeles

DEADLINE ALERT for FLGT, YSG, BCS, and OLO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Friday, October 21, 2022
Remuneration, Genetics, Time, Anti-Kickback Statute, SEC, Law, IPO, Twitter, Investment, Company, Defendant, Battle of Saint-Fulgent, Lists of schools in England, GLOBE, Suite, Stark Law, Security (finance), Mail, Holding company, Risk management, Barclays

LOS ANGELES, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • LOS ANGELES, Oct. 21, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to [email protected] .
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • The Law Offices of Frank R. Cruz, Los Angeles

DEADLINE ALERT for FLGT, YSG, BCS, OLO: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

Retrieved on: 
Thursday, October 20, 2022
Remuneration, Time, Telephone, Anti-Kickback Statute, SEC, Law, Class, IPO, Barclays, Investment, Company, Defendant, Battle of Saint-Fulgent, People's Law Office, GLOBE, Suite, Stark Law, Security (finance), Public relations

BENSALEM, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.

Key Points: 
  • BENSALEM, Pa., Oct. 20, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.
  • Investors have until the deadlines listed below to file a lead plaintiff motion.
  • Investors suffering losses on their investments are encouraged to contact the Law Offices of Howard G. Smith to discuss their legal rights in these class actions at 888-638-4847 or by email to [email protected] .
  • Law Offices of Howard G. Smith

FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

Retrieved on: 
Wednesday, October 19, 2022
Remuneration, Genetics, News, Office of Inspector General, U.S. Department of Health and Human Services, U.S. Securities and Exchange Commission, SEC, LLC, Civil investigative demand, Security (finance), Court, KSF, Anti-Kickback Statute, Justice, U.S. Department of Justice Office of Legislative Affairs, Company, Battle of Saint-Fulgent, District court, Lists of schools in England, Accusative case, GLOBE, Central District, Stark Law, Online gambling, Private investigator

This action is pending in the United States District Court for the Central District of California.

Key Points: 
  • This action is pending in the United States District Court for the Central District of California.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 21, 2022.
  • Fulgent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

FLGT DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP – Important November 21, 2022 Deadline Reminder in Fulgent Genetics, Inc. Securities Class Action Lawsuit

Retrieved on: 
Tuesday, October 18, 2022
Physician, Remuneration, Genetics, News, Insurance, Office of Inspector General, U.S. Department of Health and Human Services, SEC, Reward, NASDAQ, Patient, Anti-Kickback Statute, COPY, Justice, U.S. Department of Justice Office of Legislative Affairs, Battle of Saint-Fulgent, Medicare, District court, Stark, Genetic testing, GLOBE, Central District, Fraud, Disclosure, LLP, COVID-19, Stark Law, Health, Lead, Private investigator, Pharmaceutical industry, Architecture

The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.

Key Points: 
  • The action charges Fulgent with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the companys business, operations, and prospects.
  • Kessler Topaz Meltzer & Check, LLP encourages Fulgent investors who have suffered significant losses to contact the firm directly to acquire more information.
  • ABOUT KESSLER TOPAZ MELTZER & CHECK, LLP
    Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country and around the world.
  • The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP.

FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Tuesday, October 18, 2022
Physician, Genetics, Remuneration, News, Office of Inspector General, U.S. Department of Health and Human Services, Anti-Kickback Statute, SEC, Reward, Advertising, NASDAQ, Patient, Labour government, Court, Investment, Company, NEW, Justice, U.S. Department of Justice Office of Legislative Affairs, Battle of Saint-Fulgent, Medicare, District court, Stark, Lists of schools in England, Securities Exchange Act of 1934, Genetic testing, GLOBE, Central District, Lists of action films, The Legal 500, Disclosure, COVID-19, Stark Law, Health, Tobacco, Pharmaceutical industry, Online gambling, Security (finance)

NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • If you purchased Fulgent securities, and/or would like to discuss your legal rights and options please visit Fulgent Genetics, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm

Retrieved on: 
Monday, October 17, 2022
Remuneration, Anti-Kickback Statute, Medtronic, Reward, NASDAQ, Federal, Defendant, Q2, Lists of schools in England, Federation, News, Risk assessment, NYSE, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, SMFR, Investment, Justice, Company, Battle of Saint-Fulgent, PLTR, Genetic testing, GLOBE, Insulin, Disclosure, FDA, U.S. Department of Defense Strategy for Operating in Cyberspace, Genetics, Risk, Government, Growth, War, Intelligence, Research, Workforce, U.S. Department of Justice Office of Legislative Affairs, Stark Law, Physician, U.S. Securities and Exchange Commission, SEC, Complaint, Patient, EPS, Food, Medicare, Diabetes, COVID-19, Health, Pharmaceutical industry, Audit, Medical device, Dietary supplement, Renewable energy, Risk management, Palantir Technologies, P.C

For more information on the Sema4 class action go to: https://bespc.com/cases/SMFR

Key Points: 
  • For more information on the Sema4 class action go to: https://bespc.com/cases/SMFR
    Medtronic is a medical device company.
  • On February 7, 2020, the FDA classified Medtronics November 2019 notification as a Class I recallthe most serious type of recall.
  • For more information on the Fulgent class action go to: https://bespc.com/cases/FLGT
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Fulgent Genetics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FLGT

Retrieved on: 
Wednesday, October 19, 2022
Legal, Professional Services, Titan, LinkedIn, Genetics, Remuneration, Advertising, Class, Reward, THE, NASDAQ, Federal, Twitter, Court, Facebook, Anti-Kickback Statute, Battle of Saint-Fulgent, Medicare, WHY, TO, Lists of schools in England, Stark Law, Health, I-Space (Chinese company), Online gambling, Insurance, Tobacco, Pharmaceutical industry

WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.

Key Points: 
  • WHAT TO DO NEXT: To join the Fulgent Genetics class action, go to https://rosenlegal.com/submit-form/?case_id=8809 or call Phillip Kim, Esq.
  • WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles.
  • The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.